BTSG Overview

BrightSpring Health Services, Inc. provides complementary home- and community-based pharmacy and provider health solutions for complex populations in need of specialized and/or chronic care. Through the Company’s service lines, including pharmacy, home health care and rehabilitation, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. It provides infused, injectable, and oral medication services in the home and clinic. Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care.

Wall Street analysts forecast BTSG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BTSG is43.20 USD with a low forecast of 40.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Brightspring Health Services Inc revenue for the last quarter amounts to 3.55B USD, increased 29.26

Brightspring Health Services Inc. EPS for the last quarter amounts to 0.34 USD, increased 325.00

Brightspring Health Services Inc (BTSG) has 23500 emplpoyees as of April 17 2026.

Today BTSG has the market capitalization of 8.85B USD.